Related Experiment Video
Updated: Oct 14, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Medicare Diabetes Prevention: Enrollment Short Of Projections
1This article is part of a series on transforming health systems published with support from The Robert Wood Johnson Foundation. This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt, and build upon this work, for commercial use, provided the original work is properly cited. See https://creativecommons.org/licenses/by/4.0/. Harris Meyer (harris_meyer@yahoo.com) is a freelance writer based in Chicago, Illinois.
Medicare now covers diabetes prevention programs, but enrollment remains low for both patients and healthcare providers. Further research is needed to understand and address these participation barriers.
Area of Science:
- Public Health
- Health Services Research
- Chronic Disease Management
Background:
- Medicare coverage for diabetes prevention programs was established after extensive research demonstrating their efficacy.
- Despite coverage, uptake by beneficiaries and providers has been limited, indicating a gap between policy and practice.
Discussion:
- Barriers to enrollment for both beneficiaries and providers need to be identified and addressed to maximize program reach.
- Understanding the reasons for low participation is crucial for improving public health outcomes related to type 2 diabetes.
Key Insights:
- Medicare's decision to fund diabetes prevention signifies a policy shift towards proactive chronic disease management.
- Low enrollment rates suggest significant obstacles hindering the implementation and accessibility of these vital programs.
Outlook:
- Future efforts should focus on strategies to enhance awareness, simplify enrollment processes, and incentivize participation.
- Successful implementation of these programs could lead to a significant reduction in type 2 diabetes incidence and associated healthcare costs.
More Related Videos
Related Concept Videos
Preventive Healthcare Services
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Drug Dosing: Obese Patients
Diabetes: Symptoms, Diagnosis, and Complications

